AltoStar® SARS-CoV-2 RT-PCR Kit 1.0 RUO (#AS0821503) is a reagent system, based on real-time PCR technology, for the qualitative detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) specific RNA.

The RUO Instructions for Use are provided on our website.

UKE untersucht Häufigkeit und Schwere von COVID-19-Infektionen bei Kindern. Die Studie wird auch von altona Diagnostics gefördert.

altona Diagnostics Brasil LTDA, São Paulo, the brazilian subsidiary of altona Diagnostics GmbH, obtained the approval of the registration at ANVISA, the Brazilian Health Authority, for its real-time PCR kit to detect the RNA of SARS-CoV-2, causative agent of COVID-19.

altona Diagnostics successfully achieved CE certification for the RealStar® SARS-CoV-2 RT-PCR Kit 1.0

altona Diagnostics receives Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for RealStar® SARS-CoV-2 RT-PCR Kit U.S.

RealStar® Real-Time PCR Kits – EN (for Europe) / for UK);

RealStar® Real-Time PCR Kits – EN (for UK);

RealStar® Real-Time PCR Kit – FR;

RealStar® Real-Time PCR Kit – IT;

RealStar® Real-Time PCR Kit RUO – EN;

RealStar® Real-Time PCR Kit RUO – for Latin America (ES;PT)